A prognostic scoring system that is cheap, efficient and reliable can predict how patients with relapsed and/or metastatic head and neck cancer will respond to immunotherapy, new research has shown.

Men with particularly aggressive prostate cancers can be treated more effectively by combining an existing targeted medicine, abiraterone, with a new experimental drug to block two of cancer’s growth signals at once, a major new trial has shown.

To accelerate research and improve patient outcomes, the world’s first centre for recurrent head and neck cancer has been launched at The Royal Marsden NHS Foundation Trust thanks to Royal Marsden Cancer Charity funding. 

An artificial intelligence (AI) that reconstructs MRI images of moving tumours can do so in seconds, offering a significant improvement on current methods to optimise radiotherapy treatment in the clinic.

A new drug could become the first ever targeted brain cancer treatment, with encouraging early results from a phase 1 trial suggesting it could treat some patients with advanced disease.

Two new treatment options using immunotherapy for patients with advanced oesophageal cancer have shown significantly improved long-term survival, according to a study conducted at The Royal Marsden NHS Foundation Trust.

A new high-tech drug treatment for prostate cancer, which delivers a precisely targeted dose of radiation to cancer cells, can keep patients alive and healthy for longer, a new phase III trial reports.

Scientists can use genetic ‘weather forecasting’ to predict how long it will take for bowel cancer to evolve resistance to a drug before a patient has even started treatment, a new study has shown.

We are joining the National Institute for Health Research in celebrating International Clinical Trials Day 2021 and saying thank you to all of those involved in clinical trials.

Researchers from The Royal Marsden, The Francis Crick Institute, UCL and Cruces University Hospital have found that cells from different parts of kidney tumours behave differently, and surprisingly, cells within the centre of a tumour are the most aggressive and have the highest chance of spreading around the body.